|
| 38009241 | A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema. | Allergy | 2024 |
| 36872446 | Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being. | Allergy Asthma Proc | 2023 |
| 37805224 | Hereditary Angioedema: A Test of Our Progress. | J Allergy Clin Immunol Pract | 2023 |
| 37619776 | The US Hereditary Angioedema Association Scientific Registry: hereditary angioedema demographics, disease severity, and comorbidities. | Ann Allergy Asthma Immunol | 2023 |
| 37543185 | Lower serum 15-HETE level predicts nasal ILC2 accumulation during COX-1 inhibition in AERD. | J Allergy Clin Immunol | 2023 |
| 35787344 | Therapeutic monoclonal antibodies with a focus on hereditary angioedema. | Allergol Int | 2023 |
| 35497649 | The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update. | World Allergy Organ J | 2022 |
| 33098856 | Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: AÂ randomized, double-blind, placebo-controlled phase 3 trial. | J Allergy Clin Immunol | 2021 |
| 33866032 | Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2). | J Allergy Clin Immunol Pract | 2021 |
| 33581742 | Assessing the cost and quality-of-life impact of on-demand-only medications for adults with hereditary angioedema. | Allergy Asthma Proc | 2021 |
| 33746090 | The Expanding Spectrum of Mutations in Hereditary Angioedema. | J Allergy Clin Immunol Pract | 2021 |
| 34871158 | COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications. | Allergy Asthma Proc | 2021 |
| 34048855 | Consensus on treatment goals in hereditary angioedema: AÂ global Delphi initiative. | J Allergy Clin Immunol | 2021 |
| 33476718 | Intranasal ketorolac, diagnosis, and desensitization for aspirin-exacerbated respiratory disease. | Ann Allergy Asthma Immunol | 2021 |
| 32534150 | Association Between Self-Reported Dental Hygiene Practices and Dental Procedure-Related Recurrent Angioedema Attacks in HAE Subjects: A Multicenter Survey. | J Allergy Clin Immunol Pract | 2020 |
| 31981614 | Contact system activation during erythema marginatum in hereditary angioedema. | Ann Allergy Asthma Immunol | 2020 |
| 33109322 | Hereditary angioedema: On-demand treatment of angioedema attacks. | Allergy Asthma Proc | 2020 |
| 32605699 | What is in your pantry? Entomologic anaphylaxis. | Allergy Asthma Proc | 2020 |
| 32399057 | Correction to: The International/Canadian Hereditary Angioedema Guideline. | Allergy Asthma Clin Immunol | 2020 |
| 30660873 | Treatment effect of switching from intravenous to subcutaneous C1-inhibitor for prevention of hereditary angioedema attacks: COMPACT subgroup findings. | J Allergy Clin Immunol Pract | 2019 |
| 31788005 | The International/Canadian Hereditary Angioedema Guideline. | Allergy Asthma Clin Immunol | 2019 |
| 31801005 | Treatment of Hypertension in Patients with Asthma. Reply. | N Engl J Med | 2019 |
| 31485239 | Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study. | Allergy Asthma Clin Immunol | 2019 |
| 31509675 | Treatment of Hypertension in Patients with Asthma. | N Engl J Med | 2019 |
| 30772477 | Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks. | J Allergy Clin Immunol Pract | 2019 |
| 30550806 | Development of a health-related quality of life instrument for patients with hereditary angioedema living in the United States. | J Allergy Clin Immunol Pract | 2019 |
| 30698094 | Cost-Effectiveness of Prophylactic Medications for the Treatment of Hereditary Angioedema Due to C1 Inhibitor Deficiency: A Real-World U.S. Perspective. | J Manag Care Spec Pharm | 2019 |
| 29316335 | Exposure-Response Model of Subcutaneous C1-Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema. | CPT Pharmacometrics Syst Pharmacol | 2018 |
| 29998524 | Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema. | Clin Exp Allergy | 2018 |
| 29957871 | Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema. | Clin Exp Allergy | 2018 |
| 30033914 | Angioedema Due to Bradykinin Dysregulation. | J Allergy Clin Immunol Pract | 2018 |
| 30480729 | Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. | JAMA | 2018 |
| 29391286 | Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. | J Allergy Clin Immunol Pract | 2018 |
| 29669666 | Hereditary angioedema from the patient's perspective: A follow-up patient survey. | Allergy Asthma Proc | 2018 |
| 29410040 | Hereditary angioedema with normal C1 inhibitor: Four types and counting. | J Allergy Clin Immunol | 2018 |
| 29604336 | Mast cell disorders: Protean manifestations and treatment responses. | Ann Allergy Asthma Immunol | 2018 |
| 29318628 | The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. | Allergy | 2018 |
| 27665386 | Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives. | J Allergy Clin Immunol Pract | 2017 |
| 28283277 | Anabolic androgen use in the management of hereditary angioedema: Not so cheap after all. | Ann Allergy Asthma Immunol | 2017 |
| 28279492 | Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease. | J Allergy Clin Immunol | 2017 |
| 28328347 | Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. | N Engl J Med | 2017 |
| 28687107 | Laboratory Approaches for Assessing Contact System Activation. | Immunol Allergy Clin North Am | 2017 |
| 27818136 | Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility. | J Allergy Clin Immunol Pract | 2017 |
| 26100084 | Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33. | J Allergy Clin Immunol | 2016 |
| 26342745 | Hypertension and Asthma: A Comorbid Relationship. | J Allergy Clin Immunol Pract | 2016 |
| 26581355 | Pediatric Hereditary Angioedema: Onset, Diagnostic Delay, and Disease Severity. | Clin Pediatr (Phila) | 2016 |
| 27940765 | Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency. | Pediatrics | 2016 |
| 27329469 | Tolerability and Effectiveness of 17-α-Alkylated Androgen Therapy for Hereditary Angioedema: A Re-examination. | J Allergy Clin Immunol Pract | 2016 |
| 27130715 | Cases of acquired C1 inhibitor deficiency treated with rituximab. | J Allergy Clin Immunol Pract | 2016 |
| 27246526 | Angioedema attacks in patients with hereditary angioedema: Local manifestations of a systemic activation process. | J Allergy Clin Immunol | 2016 |